1163 related articles for article (PubMed ID: 26156025)
1. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
2. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
[TBL] [Abstract][Full Text] [Related]
6. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
Peter JG; Zijenah LS; Chanda D; Clowes P; Lesosky M; Gina P; Mehta N; Calligaro G; Lombard CJ; Kadzirange G; Bandason T; Chansa A; Liusha N; Mangu C; Mtafya B; Msila H; Rachow A; Hoelscher M; Mwaba P; Theron G; Dheda K
Lancet; 2016 Mar; 387(10024):1187-97. PubMed ID: 26970721
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
[TBL] [Abstract][Full Text] [Related]
10. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe.
Zijenah LS; Kadzirange G; Bandason T; Chipiti MM; Gwambiwa B; Makoga F; Chungu P; Kaguru P; Dheda K
BMC Infect Dis; 2016 Jan; 16():20. PubMed ID: 26797499
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
Hanifa Y; Fielding KL; Chihota VN; Adonis L; Charalambous S; Karstaedt A; McCarthy K; Nicol MP; Ndlovu NT; Sahid F; Churchyard GJ; Grant AD
PLoS One; 2016; 11(6):e0156866. PubMed ID: 27271432
[TBL] [Abstract][Full Text] [Related]
12. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
[TBL] [Abstract][Full Text] [Related]
13. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study.
Bjerrum S; Kenu E; Lartey M; Newman MJ; Addo KK; Andersen AB; Johansen IS
BMC Infect Dis; 2015 Oct; 15():407. PubMed ID: 26427365
[TBL] [Abstract][Full Text] [Related]
15. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
17. Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
Gina P; Randall PJ; Muchinga TE; Pooran A; Meldau R; Peter JG; Dheda K
BMC Infect Dis; 2017 May; 17(1):339. PubMed ID: 28499418
[TBL] [Abstract][Full Text] [Related]
18. Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial.
Naidoo P; Esmail A; Peter JG; Davids M; Fadul M; Dheda K
Int J Infect Dis; 2019 Feb; 79():37-43. PubMed ID: 30292891
[TBL] [Abstract][Full Text] [Related]
19. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
Broger T; Nicol MP; Székely R; Bjerrum S; Sossen B; Schutz C; Opintan JA; Johansen IS; Mitarai S; Chikamatsu K; Kerkhoff AD; Macé A; Ongarello S; Meintjes G; Denkinger CM; Schumacher SG
PLoS Med; 2020 May; 17(5):e1003113. PubMed ID: 32357197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
